Neurosom® Sleep Therapy

Make your investment in Sleep Health have a bigger impact! We're thrilled to give you a little more time to be a part of our extended Bonus Shares - we are offering incentives of additional shares when you invest in Neurosom - see all the details at https://lnkd.in/g4GW3c9K www.neurosom.net #sleeptherapy #sleep

Neurosom is excited to announce that our equity crowdfunding raise with RedCrow is extended! Now until the end of this year, there is more time to invest in this groundbreaking Sleep Therapy technology and join our mission to revolutionize sleep health. Our recent milestones include moving to Phase II of our National Institute of Aging clinical trail for Mild Cognitive Impairment, and being featured as AdvaMed's chosen Medical Device of the Week! https://lnkd.in/gfWMTs69 Please visit our raise page, or check out our website for more information: https://lnkd.in/g4GW3c9K www.neurosom.net Don't forget the investment is open to all, not just accredited investors! #sleep #sleeptherapy

Neurosom partner company, BEL receives FDA 510(k) clearance for SOURCERER source estimation software. “SOURCERER is a next generation software that combines an elegant and easy user interface with a faster analysis, precise results, and a managed workflow. As a stand alone software tool, or seamlessly integrated with BEL EEG System One and FLOW product EcoSystem, SOURCERER is an indispensable part of the source estimation toolkit,” adds Dr. Phan Luu, Chief Scientific Officer. Read the full press release here: https://lnkd.in/gc_feMdq www.neurosom.net www.bel.company #epilepsy #hdeeg #eeg

BEL recognizes the SFN conference 2024 and the commitment to excellence in the neuroscience community. Of special interest is the lecture by Dr. Takeshi Iwatsubo on Disease-Modifying Therapies for Alzheimer's Disease. The Sleep WISP device for home sleep improvement is currently in a clinical trial to study Mild Cognitive Impairment funded by the National Institute of Aging. https://lnkd.in/gqHwVgHX https://www.bel.company #sfn2024 #sleep #MCI

BEL recognizes the SFN conference 2024 and the commitment to excellence in the neuroscience community. Of special interest is the lecture by Dr. Takeshi Iwatsubo on Disease-Modifying Therapies for Alzheimer's Disease. The Sleep WISP device for home sleep improvement is currently in a clinical trial to study Mild Cognitive Impairment funded by the National Institute of Aging. https://lnkd.in/gqHwVgHX https://www.bel.company #SFN #sleep #MCI

Today’s #DeviceOfTheWeek features Sleep WISP Therapy from Neurosom® Sleep Therapy of Eugene, Oregon. Neurosom’s Sleep WISP Therapy is applied by the user, at home, through a headband worn during sleep. The headband system uses EEG and machine learning to accurately track the user’s sleep cycles. The system applies painless electrical stimulation to facilitate sleep onset as well as extend and enhance deep sleep. The technology is supported by Department of Defense and National Institutes of Aging grants to improve deep sleep and cognitive functions in military service members and seniors. Neurosom plans to seek a breakthrough device designation from the FDA, which would help promote access to patients.

New Webinar available now: "Transforming The Future of Therapeutics for Parkinson's Disease" - Presentation by Dr. Allison C. Waters and colleagues at The Nash Family Center for Advanced Circuit Therapeutics (Icahn School of Medicine at Mt. Sinai). Discover how neuromodulation, sleep health, and the BEL Sleep WISP are part of emerging therapeutics for the PD community. https://lnkd.in/gzpdM6-M www.bel.company www.neurosom.net #sleep #sleeptherapy #hdeeg #parkinsons

Neurosom, Inc. is proud to partner with The Nash Family Center for Advanced Circuit Therapeutics (Ichan School of Medicine at Mt. Sinai) to present our webinar: "Transforming the future of therapeutics for Parkinson's Disease (PD)" - how neuromodulation is shaping treatment - including Neurosom's WISP headband device with EEG and TES stimulation. This webinar will include brief presentations from professionals at the Center for Advanced Circuit Therapeutics as well as Q & A with the audience. Featuring laboratory director Dr. Allison C Waters, PhD and Mason Dallegge (BS, graduate student) with a presentation on the promise of at-home neuromodulation to enhance sleep health in Parkinson's Disease. Join us for this free webinar with the leading experts in groundbreaking therapy for PD, and learn how neuromodulation is making a real difference in patient care. Sep 18, 2024 10:00 AM PDT. Register here: https://lnkd.in/gQXuemW8 www.neurosom.net www.bel.company #sleep #sleeptherapy #sleephealth #parkinsonsdisease

We are pleased to invite you to join our CEO, Dr. Don Tucker, on the Unicorn Hunt podcast next week.

Neurosom Bonus Shares Extended! For a limited time, we have extended the Neurosom offering which includes bonus shares for qualified investors. See the terms at RedCrow.com. https://lnkd.in/gsSkQT7W #sleep #sleeptherapy www.neurosom.net